Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

630 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assays.
Afonso J, Lopes S, Gonçalves R, Caldeira P, Lago P, Tavares de Sousa H, Ramos J, Gonçalves AR, Ministro P, Rosa I, Vieira AI, Dias CC, Magro F; Portuguese IBD Study Group (GEDII). Afonso J, et al. Among authors: rosa i. Aliment Pharmacol Ther. 2016 Oct;44(7):684-92. doi: 10.1111/apt.13757. Epub 2016 Aug 10. Aliment Pharmacol Ther. 2016. PMID: 27507790
Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions.
Dias CC, Rodrigues PP, Coelho R, Santos PM, Fernandes S, Lago P, Caetano C, Rodrigues Â, Portela F, Oliveira A, Ministro P, Cancela E, Vieira AI, Barosa R, Cotter J, Carvalho P, Cremers I, Trabulo D, Caldeira P, Antunes A, Rosa I, Moleiro J, Peixe P, Herculano R, Gonçalves R, Gonçalves B, Sousa HT, Contente L, Morna H, Lopes S, Magro F; on behalf GEDII. Dias CC, et al. Among authors: rosa i. J Crohns Colitis. 2017 Apr 1;11(4):445-453. doi: 10.1093/ecco-jcc/jjw171. J Crohns Colitis. 2017. PMID: 27683799
Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays.
Afonso J, Lopes S, Gonçalves R, Caldeira P, Lago P, Tavares de Sousa H, Ramos J, Gonçalves AR, Ministro P, Rosa I, Vieira AI, Coelho R, Tavares P, Soares J, Sousa AL, Carvalho D, Sousa P, da Silva JP, Meira T, Silva Ferreira F, Dias CC, Chowers Y, Ben-Horin S, Magro F; on behalf Portuguese IBD Study Group (GEDII). Afonso J, et al. Among authors: rosa i. Therap Adv Gastroenterol. 2016 Nov;9(6):781-794. doi: 10.1177/1756283X16658223. Epub 2016 Jul 26. Therap Adv Gastroenterol. 2016. PMID: 27803733 Free PMC article.
Erratum: Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions.
Dias CC, Rodrigues PP, Coelho R, Santos PM, Fernandes S, Lago P, Caetano C, Rodrigues Â, Portela F, Oliveira A, Ministro P, Cancela E, Vieira AI, Barosa R, Cotter J, Carvalho P, Cremers I, Trabulo D, Caldeira P, Antunes A, Rosa I, Moleiro J, Peixe P, Herculano R, Gonçalves R, Gonçalves B, Sousa HT, Contente L, Morna H, Lopes S, Magro F; on behalf GEDII. Dias CC, et al. Among authors: rosa i. J Crohns Colitis. 2017 Apr 1;11(4):515. doi: 10.1093/ecco-jcc/jjw207. J Crohns Colitis. 2017. PMID: 27927719 No abstract available.
Impact of Early Surgery and Immunosuppression on Crohn's Disease Disabling Outcomes.
Magro F, Dias CC, Coelho R, Santos PM, Fernandes S, Caetano C, Rodrigues Â, Portela F, Oliveira A, Ministro P, Cancela E, Vieira AI, Barosa R, Cotter J, Carvalho P, Cremers I, Trabulo D, Caldeira P, Antunes A, Rosa I, Moleiro J, Peixe P, Herculano R, Gonçalves R, Gonçalves B, Tavares Sousa H, Contente L, Morna H, Lopes S. Magro F, et al. Among authors: rosa i. Inflamm Bowel Dis. 2017 Feb;23(2):289-297. doi: 10.1097/MIB.0000000000001007. Inflamm Bowel Dis. 2017. PMID: 28107278
Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation.
Magro F, Afonso J, Lopes S, Coelho R, Gonçalves R, Caldeira P, Lago P, de Sousa HT, Ramos J, Gonçalves AR, Ministro P, Rosa I, Vieira AI, Andrade P, Soares JB, Carvalho D, Sousa P, Meira T, Lopes J, Moleiro J, Dias CC, Falcão A, Geboes K, Carneiro F; Portuguese IBD Study Group (GEDII). Magro F, et al. Among authors: rosa i. EBioMedicine. 2017 Jul;21:123-130. doi: 10.1016/j.ebiom.2017.06.004. Epub 2017 Jun 7. EBioMedicine. 2017. PMID: 28629912 Free PMC article.
Clinical performance of an infliximab rapid quantification assay.
Magro F, Afonso J, Lopes S, Coelho R, Gonçalves R, Caldeira P, Lago P, de Sousa HT, Ramos J, Gonçalves AR, Ministro P, Rosa I, Meira T, Andrade P, Soares JB, Carvalho D, Sousa P, Vieira AI, Lopes J, Dias CC, Geboes K, Carneiro F. Magro F, et al. Among authors: rosa i. Therap Adv Gastroenterol. 2017 Sep;10(9):651-660. doi: 10.1177/1756283X17722916. Epub 2017 Aug 11. Therap Adv Gastroenterol. 2017. PMID: 28932267 Free PMC article.
630 results